Navigation Links
S.C. BlueCross BlueShield Receives URAC Case Management Accreditation
Date:11/20/2007

t, information management, oversight of delegated functions, ethics, complaints, and the case management process.

URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit http://www.urac.org.

Headquartered in Columbia, S.C., BlueCross BlueShield of South Carolina (http://www.SouthCarolinaBlues.com) is an independent licensee of the Blue Cross and Blue Shield Association. BlueCross BlueShield of South Carolina and its family of companies include more than 20 subsidiaries involved in health insurance services, U.S. DoD health program and Medicare contracts, and other insurance and employee benefits services.


'/>"/>
SOURCE BlueCross BlueShield of South Carolina
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
2. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
3. Harvard Researchers Select S.C. BlueCross for National Honor
4. National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
5. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
6. BlueCross Receives Federal Approval for 2008 Medicare Plans
7. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
8. Empire BlueCross BlueShield Announces Release of State Health Index Data
9. Empire BlueCross BlueShield and New York Attorney General Reach Agreement on Guidelines for State Doctor Ranking Programs
10. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
11. DaVita Receives Civil Complaint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...HAT: , The Sixth International Chronic Total Occl...ng state-of-the-art technologies, research finding...hat are essential for interventional cardiologists...oronary occlusions. The conference will include pr... sessions, and numerous thematically organized liv...
(Date:1/7/2009)...e novel design of a deep muscle along the spinal c...key to spinal support and a healthy back, accordin...San Diego School of Medicine. Their findings abou...this poorly understood muscle has been published o...rnal of Bone and Joint Surgery . , "The multifi...
(Date:1/7/2009)...WHITE PLAINS, N.Y. and KANSAS CITY, Kan., Jan. 7 /... (LLS) and The University of Kansas Cancer Cente...eries by LLS-funded researchers into Phase I clini...ansas Cancer Center (KU Cancer Center) and its pa...o early stage projects of LLS-funded researchers a...
(Date:1/7/2009)...Plastic Surgeons Kick-Off 2009 with Mission Trips ...Ill., Jan. 7 Parents of... one New Year,s resolution, to make sure their chi...olution will be met. Building on a tradition of v...can Society of Plastic Surgeons (ASPS) will usher ...
Breaking Medicine News(10 mins):Health News:Unique skeletal muscle design contributes to spine stability 2Health News:The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development 2Health News:The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development 3Health News:New Year Brings New Hope to Children Born With Cleft Lip, Palate 2Health News:New Year Brings New Hope to Children Born With Cleft Lip, Palate 3
...ttributed the rising rates of mortality in kidney ...sed levels of heparin antibodies in their bodies. ...oceedings // is a preliminary look at one aspect a...dergo hemodialysis. In the study, they found patie...
...be detected early if the early symptoms are not ne... the aggressiveness of the fast growing tumor. // ...kely to visit a doctor and report symptoms such as... these symptoms are taken into careful considerati...
...understanding the genetic pathway involved in the ...on how sensory hair cells in the ear –– the cells ...que shapes that enable the perception of sound. S...ner ear, the hair cells transform the mechanical v...
...for surgeries, often depend on the Internet to pro...crucial decision regarding the treatment procedure... Archives of Otolaryngology-Head & Neck Surgery, p...o outpatient otolaryngology procedures turned to t...
Other Medicine News:Health News:Internet Helps Patients In Finding Info About Their Children's' Health Conditions 2
(Date:1/5/2009)...ESDA, Md., Jan. 5 Microm...ompany developing novel, proprietary,antibodies f...mmune diseases,provides an outlook on key events...t intends to provide an update on its research and..., -- April 12 to 16, 2009: Update on several ...
(Date:12/29/2008)..., Md., Dec. 29 The winn...rch Protection was announced today by Dr. Peter G....Improvement Institute. , , The winner of the a...nderson Cancer Center -- for its best practice "...gram provides for 1) enhanced human subjects prote...
(Date:12/17/2008)...milestone met in development and validation of non...D, Mass., Dec. 17 MatTek Corporati...ory Committee (ESAC) endorsed the scientific valid...SIT) at its November meeting. ESAC concluded that...and reliability for the prediction of skin irritat...
(Date:12/17/2008)...O, Dec. 17 Medivation, I... completed patient enrollment in a,Phase 1-2 dose...ndrogen,receptor antagonist, in castration-resist...ek approval from the U.S. Food and Drug Administra...next year. , The open-label, U.S. Phase 1-2...
Breaking Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Holiday Gifts That Help Fight Alzheimers Disease 4001 1Holiday Gifts That Help Fight Alzheimers Disease 4001 2OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 1OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 2Federal Charges Filed Against Community Medical Centers Management 3994 1Federal Charges Filed Against Community Medical Centers Management 3994 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 557 1StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 557 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 557 3
...E, June 04, 2007 /PRNewswire-FirstCall/ -- ZymoGen...were presented from a,Phase 1b clinical trial with...(B-CLL) at the American Society of Clinical,Oncolo...intravenous,administration of higher doses than ha...t atacicept was well-tolerated and biologically,ac...
...NE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda,Th... that the,Company presented a "meta-analysis" or c...ine-SR in multiple sclerosis during a,poster sessi...earch,in MS (ACTRIMS) Meeting in Washington, D.C. ... of Consistent Improvement in Walking,Speed on the...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...-FILL Capillary Blood Collection Tubes are 100% pl...e for a wide range of applications, the Capillary ...y tube, attached cap and a micro tube.,The ca...od into the micro tube thereby eliminating the ten...
...-FILL Capillary Blood Collection Tubes are 100% pl...e for a wide range of applications, the Capillary ...y tube, attached cap and a micro tube.,The ca...od into the micro tube thereby eliminating the ten...
...-FILL Capillary Blood Collection Tubes are 100% pl...e for a wide range of applications, the Capillary ...y tube, attached cap and a micro tube.,The ca...od into the micro tube thereby eliminating the ten...
...-FILL Capillary Blood Collection Tubes are 100% pl...e for a wide range of applications, the Capillary ...y tube, attached cap and a micro tube.,The ca...od into the micro tube thereby eliminating the ten...
Medicine Products: